STACY ROTH: Open Payments
NPI 1689077018 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,972 in 92 payments from 16 companies in 2025. Trend: 2023 $653 · 2024 $982 · 2025 $1,972
Food & beverage: $1,972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $331 |
| E.R. Squibb & Sons, L.L.C. | 10 | $235 |
| Alkermes, Inc. | 12 | $233 |
| Axsome Therapeutics, Inc. | 6 | $231 |
| Vanda Pharmaceuticals Inc. | 9 | $177 |
| Otsuka America Pharmaceutical, Inc. | 13 | $157 |
| Braeburn Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $69 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
Products named: VRAYLAR, COBENFY, Auvelity, FANAPT, BRIXADI, LYBALVI, ABILIFY ASIMTUFII, REXULTI.
Industry payments across IA — which companies pay providers there.
